Found: 6
Select item for more details and to access through your institution.
A North American Cohort of Anti‐SAE Dermatomyositis: Clinical Phenotype, Testing, and Review of Cases.
- Published in:
- ACR Open Rheumatology, 2021, v. 3, n. 5, p. 287, doi. 10.1002/acr2.11247
- By:
- Publication type:
- Article
Clinical Features and Immunogenetic Risk Factors Associated With Additional Autoantibodies in Anti‐Transcriptional Intermediary Factor 1γ Juvenile‐Onset Dermatomyositis.
- Published in:
- Arthritis & Rheumatology, 2024, v. 76, n. 4, p. 631, doi. 10.1002/art.42768
- By:
- Publication type:
- Article
Distinct Scleroderma Autoantibody Profiles Stratify Patients for Cancer Risk at Scleroderma Onset and During the Disease Course.
- Published in:
- Arthritis & Rheumatology, 2024, v. 76, n. 1, p. 68, doi. 10.1002/art.42663
- By:
- Publication type:
- Article
Long‐term extension study of tofacitinib in refractory dermatomyositis.
- Published in:
- 2022
- By:
- Publication type:
- Letter to the Editor
Study of Tofacitinib in Refractory Dermatomyositis: An Open‐Label Pilot Study of Ten Patients.
- Published in:
- Arthritis & Rheumatology, 2021, v. 73, n. 5, p. 858, doi. 10.1002/art.41602
- By:
- Publication type:
- Article
Enrichment of Scleroderma Vascular Disease-Associated Autoantigens in Endothelial Lineage Cells.
- Published in:
- Arthritis & Rheumatology, 2016, v. 68, n. 10, p. 2540, doi. 10.1002/art.39743
- By:
- Publication type:
- Article